Cargando…

An Ovarian Steroid Metabolomic Pathway Analysis in Basal and Polycystic Ovary Syndrome (PCOS)-like Gonadotropin Conditions Reveals a Hyperandrogenic Phenotype Measured by Mass Spectrometry

Prior work has demonstrated that murine ovarian explants and isolated ovarian follicles can recapitulate human-like 28-day cycles in vitro with normal patterns of estradiol and progesterone secretion in response to gonadotropin stimulation. The objective of this study was to manipulate the gonadotro...

Descripción completa

Detalles Bibliográficos
Autores principales: Gargus, Emma S., Bae, Yeunook, Chen, Jiexi, Moss, Kristine J., Ingram, Asia N., Zhang, Jiyang, Montgomery, Nathan T., Boots, Christina E., Funk, William E., Woodruff, Teresa K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313004/
https://www.ncbi.nlm.nih.gov/pubmed/35884951
http://dx.doi.org/10.3390/biomedicines10071646
_version_ 1784753972643364864
author Gargus, Emma S.
Bae, Yeunook
Chen, Jiexi
Moss, Kristine J.
Ingram, Asia N.
Zhang, Jiyang
Montgomery, Nathan T.
Boots, Christina E.
Funk, William E.
Woodruff, Teresa K.
author_facet Gargus, Emma S.
Bae, Yeunook
Chen, Jiexi
Moss, Kristine J.
Ingram, Asia N.
Zhang, Jiyang
Montgomery, Nathan T.
Boots, Christina E.
Funk, William E.
Woodruff, Teresa K.
author_sort Gargus, Emma S.
collection PubMed
description Prior work has demonstrated that murine ovarian explants and isolated ovarian follicles can recapitulate human-like 28-day cycles in vitro with normal patterns of estradiol and progesterone secretion in response to gonadotropin stimulation. The objective of this study was to manipulate the gonadotropin stimulation protocol to mimic polycystic ovary syndrome (PCOS) and assess the resulting changes in ovarian steroidogenesis. A secondary aim of the study was to develop a high-throughput, sensitive, and specific liquid chromatography with tandem mass spectrometry (LC-MS/MS) assay to measure seven steroid hormones (estrone, estradiol, progesterone, testosterone, androstenedione, dehydroepiandrosterone, and dihydrotestosterone) in conditioned culture media. Ovaries were harvested from 12-day-old CD-1 mice and cultured for 28 days, with ovulation induction on culture day 14. Media were supplemented human chorionic gonadotropin (hCG, a luteinizing hormone analog) and follicle stimulating hormone (FSH) at ratios of 1:0 (standard media), 1:1 (physiologic ratio), and 3:1 (PCOS-like ratio). Ovaries cultured in PCOS-like media displayed hyperandrogenism and impaired ovulation, two key features of a PCOS-like phenotype. Taken together, this first-of-its-kind presentation of hormone levels from single tissues creates a map of the enzymatic steps most acutely affected by gonadotropin dysregulation and may provide opportunities for assessing other potential insults in PCOS pathogenesis.
format Online
Article
Text
id pubmed-9313004
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-93130042022-07-26 An Ovarian Steroid Metabolomic Pathway Analysis in Basal and Polycystic Ovary Syndrome (PCOS)-like Gonadotropin Conditions Reveals a Hyperandrogenic Phenotype Measured by Mass Spectrometry Gargus, Emma S. Bae, Yeunook Chen, Jiexi Moss, Kristine J. Ingram, Asia N. Zhang, Jiyang Montgomery, Nathan T. Boots, Christina E. Funk, William E. Woodruff, Teresa K. Biomedicines Article Prior work has demonstrated that murine ovarian explants and isolated ovarian follicles can recapitulate human-like 28-day cycles in vitro with normal patterns of estradiol and progesterone secretion in response to gonadotropin stimulation. The objective of this study was to manipulate the gonadotropin stimulation protocol to mimic polycystic ovary syndrome (PCOS) and assess the resulting changes in ovarian steroidogenesis. A secondary aim of the study was to develop a high-throughput, sensitive, and specific liquid chromatography with tandem mass spectrometry (LC-MS/MS) assay to measure seven steroid hormones (estrone, estradiol, progesterone, testosterone, androstenedione, dehydroepiandrosterone, and dihydrotestosterone) in conditioned culture media. Ovaries were harvested from 12-day-old CD-1 mice and cultured for 28 days, with ovulation induction on culture day 14. Media were supplemented human chorionic gonadotropin (hCG, a luteinizing hormone analog) and follicle stimulating hormone (FSH) at ratios of 1:0 (standard media), 1:1 (physiologic ratio), and 3:1 (PCOS-like ratio). Ovaries cultured in PCOS-like media displayed hyperandrogenism and impaired ovulation, two key features of a PCOS-like phenotype. Taken together, this first-of-its-kind presentation of hormone levels from single tissues creates a map of the enzymatic steps most acutely affected by gonadotropin dysregulation and may provide opportunities for assessing other potential insults in PCOS pathogenesis. MDPI 2022-07-08 /pmc/articles/PMC9313004/ /pubmed/35884951 http://dx.doi.org/10.3390/biomedicines10071646 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Gargus, Emma S.
Bae, Yeunook
Chen, Jiexi
Moss, Kristine J.
Ingram, Asia N.
Zhang, Jiyang
Montgomery, Nathan T.
Boots, Christina E.
Funk, William E.
Woodruff, Teresa K.
An Ovarian Steroid Metabolomic Pathway Analysis in Basal and Polycystic Ovary Syndrome (PCOS)-like Gonadotropin Conditions Reveals a Hyperandrogenic Phenotype Measured by Mass Spectrometry
title An Ovarian Steroid Metabolomic Pathway Analysis in Basal and Polycystic Ovary Syndrome (PCOS)-like Gonadotropin Conditions Reveals a Hyperandrogenic Phenotype Measured by Mass Spectrometry
title_full An Ovarian Steroid Metabolomic Pathway Analysis in Basal and Polycystic Ovary Syndrome (PCOS)-like Gonadotropin Conditions Reveals a Hyperandrogenic Phenotype Measured by Mass Spectrometry
title_fullStr An Ovarian Steroid Metabolomic Pathway Analysis in Basal and Polycystic Ovary Syndrome (PCOS)-like Gonadotropin Conditions Reveals a Hyperandrogenic Phenotype Measured by Mass Spectrometry
title_full_unstemmed An Ovarian Steroid Metabolomic Pathway Analysis in Basal and Polycystic Ovary Syndrome (PCOS)-like Gonadotropin Conditions Reveals a Hyperandrogenic Phenotype Measured by Mass Spectrometry
title_short An Ovarian Steroid Metabolomic Pathway Analysis in Basal and Polycystic Ovary Syndrome (PCOS)-like Gonadotropin Conditions Reveals a Hyperandrogenic Phenotype Measured by Mass Spectrometry
title_sort ovarian steroid metabolomic pathway analysis in basal and polycystic ovary syndrome (pcos)-like gonadotropin conditions reveals a hyperandrogenic phenotype measured by mass spectrometry
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313004/
https://www.ncbi.nlm.nih.gov/pubmed/35884951
http://dx.doi.org/10.3390/biomedicines10071646
work_keys_str_mv AT gargusemmas anovariansteroidmetabolomicpathwayanalysisinbasalandpolycysticovarysyndromepcoslikegonadotropinconditionsrevealsahyperandrogenicphenotypemeasuredbymassspectrometry
AT baeyeunook anovariansteroidmetabolomicpathwayanalysisinbasalandpolycysticovarysyndromepcoslikegonadotropinconditionsrevealsahyperandrogenicphenotypemeasuredbymassspectrometry
AT chenjiexi anovariansteroidmetabolomicpathwayanalysisinbasalandpolycysticovarysyndromepcoslikegonadotropinconditionsrevealsahyperandrogenicphenotypemeasuredbymassspectrometry
AT mosskristinej anovariansteroidmetabolomicpathwayanalysisinbasalandpolycysticovarysyndromepcoslikegonadotropinconditionsrevealsahyperandrogenicphenotypemeasuredbymassspectrometry
AT ingramasian anovariansteroidmetabolomicpathwayanalysisinbasalandpolycysticovarysyndromepcoslikegonadotropinconditionsrevealsahyperandrogenicphenotypemeasuredbymassspectrometry
AT zhangjiyang anovariansteroidmetabolomicpathwayanalysisinbasalandpolycysticovarysyndromepcoslikegonadotropinconditionsrevealsahyperandrogenicphenotypemeasuredbymassspectrometry
AT montgomerynathant anovariansteroidmetabolomicpathwayanalysisinbasalandpolycysticovarysyndromepcoslikegonadotropinconditionsrevealsahyperandrogenicphenotypemeasuredbymassspectrometry
AT bootschristinae anovariansteroidmetabolomicpathwayanalysisinbasalandpolycysticovarysyndromepcoslikegonadotropinconditionsrevealsahyperandrogenicphenotypemeasuredbymassspectrometry
AT funkwilliame anovariansteroidmetabolomicpathwayanalysisinbasalandpolycysticovarysyndromepcoslikegonadotropinconditionsrevealsahyperandrogenicphenotypemeasuredbymassspectrometry
AT woodruffteresak anovariansteroidmetabolomicpathwayanalysisinbasalandpolycysticovarysyndromepcoslikegonadotropinconditionsrevealsahyperandrogenicphenotypemeasuredbymassspectrometry
AT gargusemmas ovariansteroidmetabolomicpathwayanalysisinbasalandpolycysticovarysyndromepcoslikegonadotropinconditionsrevealsahyperandrogenicphenotypemeasuredbymassspectrometry
AT baeyeunook ovariansteroidmetabolomicpathwayanalysisinbasalandpolycysticovarysyndromepcoslikegonadotropinconditionsrevealsahyperandrogenicphenotypemeasuredbymassspectrometry
AT chenjiexi ovariansteroidmetabolomicpathwayanalysisinbasalandpolycysticovarysyndromepcoslikegonadotropinconditionsrevealsahyperandrogenicphenotypemeasuredbymassspectrometry
AT mosskristinej ovariansteroidmetabolomicpathwayanalysisinbasalandpolycysticovarysyndromepcoslikegonadotropinconditionsrevealsahyperandrogenicphenotypemeasuredbymassspectrometry
AT ingramasian ovariansteroidmetabolomicpathwayanalysisinbasalandpolycysticovarysyndromepcoslikegonadotropinconditionsrevealsahyperandrogenicphenotypemeasuredbymassspectrometry
AT zhangjiyang ovariansteroidmetabolomicpathwayanalysisinbasalandpolycysticovarysyndromepcoslikegonadotropinconditionsrevealsahyperandrogenicphenotypemeasuredbymassspectrometry
AT montgomerynathant ovariansteroidmetabolomicpathwayanalysisinbasalandpolycysticovarysyndromepcoslikegonadotropinconditionsrevealsahyperandrogenicphenotypemeasuredbymassspectrometry
AT bootschristinae ovariansteroidmetabolomicpathwayanalysisinbasalandpolycysticovarysyndromepcoslikegonadotropinconditionsrevealsahyperandrogenicphenotypemeasuredbymassspectrometry
AT funkwilliame ovariansteroidmetabolomicpathwayanalysisinbasalandpolycysticovarysyndromepcoslikegonadotropinconditionsrevealsahyperandrogenicphenotypemeasuredbymassspectrometry
AT woodruffteresak ovariansteroidmetabolomicpathwayanalysisinbasalandpolycysticovarysyndromepcoslikegonadotropinconditionsrevealsahyperandrogenicphenotypemeasuredbymassspectrometry